Genetic Study of Familial Uveal Melanoma. Association of Uveal and Cutaneous Melanoma with Cutaneous and Ocular Nevi

Ophthalmology

Volumn 114, Issue 4, 2007, Pages 774-779

  Smith, Jennifer H ^a,b   Padnick Silver, Lissa ^a   Newlin, Anna ^c   Rhodes, Katrina ^b   Rubinstein, Wendy S ^b,c  

^a Division of Ophthalmology   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Center for Medical Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DISEASE COURSE; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EYE EXAMINATION; FAMILY HISTORY; FEMALE; HEREDITY; HUMAN; MALE; MEDLINE; MELANOMA; NEVUS; P14ARF GENE; P16INK4A GENE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SIBLING; SKIN EXAMINATION; SKIN TUMOR; TUMOR SUPPRESSOR GENE; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; PEDIGREE; QUESTIONNAIRES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF; UVEAL NEOPLASMS;

EID: 33947713107     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.08.041     Document Type: Article

References (54)

1. Raivio I. Uveal melanoma in Finland: an epidemiological, clinical, histological and prognostic study. Acta Ophthalmol Suppl 133 (1977) 1-64
2. Jensen O.A. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol (Copenh) 60 (1982) 161-182
3. Singh A.D., Shields C.L., Shields J.A., and De Potter P. Bilateral primary uveal melanoma: bad luck or bad genes?. Ophthalmology 103 (1996) 256-262
4. Singh A.D., Wang M.X., Donoso L.A., et al. Familial uveal melanoma. III. Is the occurrence of familial uveal melanoma coincidental?. Arch Ophthalmol 114 (1996) 1101-1104
5. Singh A.D., Demirci H., Shields C.L., et al. Concurrent choroidal melanoma in son and father. Am J Ophthalmol 130 (2000) 679-680
6. Lynch H.T., Anderson D.E., and Krush A.J. Heredity and intraocular malignant melanoma. Study of two families and review of forty-five cases. Cancer 21 (1968) 119-125
7. Lynch H.T., Fusaro R.M., Pester J., et al. Tumour spectrum in the FAMMM syndrome. Br J Cancer 44 (1981) 553-560
8. Rizos H., Darmanian A.P., Holland E.A., et al. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF. J Biol Chem 276 (2001) 41424-41434
9. Prescher G., Bornfeld N., and Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst 82 (1990) 1765-1769
10. Sisley K., Rennie I.G., Parsons M.A., et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 19 (1997) 22-28
11. Vajdic C.M., Hutchins A.M., Kricker A., et al. Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study. Cancer Genet Cytogenet 144 (2003) 12-17
12. Parrella P., Fazio V.M., Gallo A.P., et al. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res 63 (2003) 8507-8510
13. Singh A.D., Donoso L.A., Jackson L., et al. Familial uveal melanoma: absence of constitutional cytogenic abnormalities in 14 cases [letter]. Arch Ophthalmol 114 (1996) 502-503
14. White V.A., McNeil B.K., and Horsman D.E. Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma. Cancer Genet Cytogenet 102 (1998) 40-45
15. Tschentscher F., Husing J., Holter T., et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 63 (2003) 2578-2584
16. Prescher G., Bornfeld N., Hirche H., et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347 (1996) 1222-1225
17. Tobal K., Warren W., Cooper C.S., et al. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 66 (1992) 900-904
18. Brantley Jr. M.A., and Harbour J.W. Deregulation of the Rb and p53 pathways in uveal melanoma. Am J Pathol 157 (2000) 1795-1801
19. Brantley Jr. M.A., and Harbour J.W. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region. Cancer Res 60 (2000) 4320-4323
20. Myatt N., Aristodemou P., Neale M.H., et al. Abnormalities of the transforming growth factor-beta pathway in ocular melanoma. J Pathol 192 (2000) 511-518
21. van der Velden P.A., Metzelaar-Blok J.A., Bergman W., et al. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma. Cancer Res 61 (2001) 5303-5306
22. Tschentscher F., Prescher G., Horsman D.E., et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res 61 (2001) 3439-3442
23. Ohta M., Nagai H., Shimizu M., et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 54 (1994) 5269-5272
24. Soufir N., Bressac-de Paillerets B., Desjardins L., et al. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Br J Cancer 82 (2000) 818-822
25. Hearle N., Damato B.E., Humphreys J., et al. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci 44 (2003) 458-462
26. Kannengiesser C., Avril M.F., Spatz A., et al. CDKN2A as a uveal and cutaneous melanoma susceptibility gene. Genes Chromosomes Cancer 38 (2003) 265-268
27. Elwood J.M., and Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 73 (1997) 198-203
28. Egan K.M., Seddon J.M., Glynn R.J., et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32 (1988) 239-251
29. Metzelaar-Blok J.A., ter Huurne J.A., Hurks H.M., et al. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients. Invest Ophthalmol Vis Sci 42 (2001) 1951-1954
30. Gallagher R.P., Elwood J.M., Rootman J., et al. Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 74 (1985) 775-778
31. Tucker M.A., Shields J.A., Hartge P., et al. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 313 (1985) 789-792
32. Harbour J.W., Brantley Jr. M.A., Hollingsworth H., and Gordon M. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol 88 (2004) 39-43
33. Zigman S. Effects of near ultraviolet radiation on the lens and retina. Doc Ophthalmol 55 (1983) 375-391
34. Holly E.A., Aston D.A., Ahn D.K., and Smith A.H. Intraocular melanoma linked to occupations and chemical exposures. Epidemiology 7 (1996) 55-61
35. Guenel P., Laforest L., Cyr D., et al. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control 12 (2001) 451-459
36. Glanz K., Schoenfeld E., Weinstock M.A., et al. Development and reliability of a brief skin cancer risk assessment tool. Cancer Detect Prev 27 (2003) 311-315
37. Canning C.R., and Hungerford J. Familial uveal melanoma. Br J Ophthalmol 72 (1988) 241-243
38. Jay M., and McCartney A.C. Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol 37 (1993) 457-462
39. Young L.H., Egan K.M., Walsh S.M., and Gragoudas E.S. Familial uveal melanoma. Am J Ophthalmol 117 (1994) 516-520
40. Bercher L., Munier F., Zografos L., et al. Familial uveal melanoma [in German]. Klin Monatsbl Augenheilkd 206 (1995) 384-387
41. Singh A.D., Shields C.L., De Potter P., et al. Familial uveal melanoma: clinical observations on 56 patients. Arch Ophthalmol 114 (1996) 392-399
42. Wang X., Egan K.M., Gragoudas E.S., and Kelsey K.T. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res 6 (1996) 405-410
43. van Hees C.L., Jager M.J., Bleeker J.C., et al. Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives. Melanoma Res 8 (1998) 175-180
44. Krygier G., Lombardo K., Vargas C., et al. Familial uveal melanoma: report on three sibling cases [letter]. Br J Ophthalmol 85 (2001) 1007-1008
45. Kodjikian L., Nguyen K., Lumbroso L., et al. Familial uveal melanoma: a report on two families and a review of the literature. Acta Ophthalmol Scand 81 (2003) 389-395
46. Barker-Griffith A.E., and Streeten B.W. Familial uveal melanoma: a report of four cases in two families and literature review. Can J Ophthalmol 39 (2004) 403-408
47. Singh A.D., Croce C.M., Wary K.K., et al. Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16). Ophthalmic Genet 17 (1996) 39-40
48. Richtig E., Langmann G., Mullner K., and Smolle J. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Ophthalmologica 218 (2004) 111-114
49. Vajdic C.M., Kricker A., Giblin M., et al. Eye color and cutaneous nevi predict risk of ocular melanoma in Australia. Int J Cancer 92 (2001) 906-912
50. Bataille V., Sasieni P., Cuzick J., et al. Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer 60 (1995) 622-626
51. Hurst E.A., Harbour J.W., and Cornelius L.A. Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol 139 (2003) 1067-1073
52. Toth-Molnar E., Olah J., Dobozy A., and Hammer H. Ocular pigmented findings in patients with dysplastic naevus syndrome. Melanoma Res 14 (2004) 43-47
53. Jonsson G., Bendahl P.O., Sandberg T., et al. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst 97 (2005) 1377-1382
54. Kefford R.F., Newton Bishop J.A., Bergman W., and Tucker M.A. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 17 (1999) 3245-3251